id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2021-E-0381-0006,FDA,FDA-2021-E-0381,Determination of Regulatory Review Period for Purposes of Patent Extension; TISSUEBLUE,Notice,Determinations,2022-11-09T05:00:00Z,2022,11,2022-11-09T05:00:00Z,2023-01-10T04:59:59Z,2022-11-09T13:42:05Z,2022-24434,0,0,090000648549d0f1
FDA-2021-E-0381-0005,FDA,FDA-2021-E-0381,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2022-09-08T04:00:00Z,2022,9,2022-09-08T04:00:00Z,,2022-09-08T15:58:18Z,,0,0,09000064852cdb10